Patent cliffs & loss of exclusivity
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited.
| AngelList URL | https://angel.co/company/autolus |
|---|---|
| Legal Name | Autolus Therapeutics plc |
| Company Operating Status | Active |
| Contact Page URL | https://www.autolus.com/contact-us/ |
| Crunchbase URL | https://www.crunchbase.com/organization/autolus-limited |
| Email format | {f}.{last} |
| Full Address | 191 Wood Lane White City London W12 7FP |
| Legal Entity Identifier | 549300C0KZP8EYROLL02 |
Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.